Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (SHA:600436)
China · Delayed Price · Currency is CNY 116.60
-0.71 (-0.61%)
Sep 16, 2026, 3:00 PM CST
SHA:600436 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 70,347 | 101,828 | 129,412 | 145,997 | 174,033 | 263,740 | |
Market Cap Growth | -42.28% | -21.32% | -11.36% | -16.11% | -34.01% | 63.41% |
Enterprise Value | 68,273 | 102,108 | 127,896 | 144,884 | 173,032 | 258,268 |
Last Close Price | 116.60 | 166.86 | 208.68 | 231.95 | 275.29 | 415.63 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 38.87 | 47.17 | 43.47 | 52.19 | 70.39 | 108.45 |
Forward PE | 32.25 | 32.06 | 37.47 | 42.87 | 70.44 | 94.42 |
PS Ratio | 8.58 | 11.31 | 12.00 | 14.52 | 20.02 | 32.88 |
PB Ratio | 4.64 | 6.75 | 8.72 | 10.49 | 14.72 | 26.02 |
P/TBV Ratio | 4.93 | 7.14 | 9.24 | 11.16 | 15.81 | 27.81 |
P/FCF Ratio | 92.57 | - | 527.32 | 70.71 | 25.98 | 712.61 |
P/OCF Ratio | 53.05 | 1321.98 | 98.51 | 66.16 | 25.32 | 570.53 |
PEG Ratio | - | 8.26 | 2.02 | 2.07 | 2.61 | 2.36 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 8.33 | 11.34 | 11.86 | 14.40 | 19.90 | 32.20 |
EV/EBITDA Ratio | 36.74 | 44.83 | 36.80 | 43.93 | 59.73 | 90.50 |
EV/EBIT Ratio | 39.00 | 46.46 | 37.39 | 44.86 | 60.73 | 94.00 |
EV/FCF Ratio | 89.84 | - | 521.14 | 70.17 | 25.84 | 697.82 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.07 | 0.07 | 0.08 | 0.08 | 0.09 | 0.09 |
Debt / EBITDA Ratio | 0.56 | 0.46 | 0.33 | 0.35 | 0.38 | 0.31 |
Debt / FCF Ratio | 1.36 | - | 4.68 | 0.56 | 0.17 | 2.39 |
Net Debt / Equity Ratio | -0.17 | -0.10 | -0.26 | -0.65 | -0.64 | -0.61 |
Net Debt / EBITDA Ratio | -1.43 | -0.65 | -1.11 | -2.73 | -2.62 | -2.18 |
Net Debt / FCF Ratio | -3.43 | 5.65 | -15.72 | -4.36 | -1.13 | -16.81 |
Asset Turnover | 0.44 | 0.51 | 0.62 | 0.64 | 0.64 | 0.71 |
Inventory Turnover | 0.90 | 0.98 | 1.48 | 1.79 | 1.87 | 1.72 |
Quick Ratio | 1.60 | 1.62 | 2.51 | 3.91 | 3.85 | 3.70 |
Current Ratio | 3.70 | 5.02 | 4.77 | 5.24 | 5.06 | 4.98 |
Return on Equity (ROE) | 11.73% | 14.32% | 20.83% | 22.15% | 22.98% | 26.80% |
Return on Assets (ROA) | 5.88% | 7.83% | 12.35% | 12.74% | 13.13% | 15.11% |
Return on Invested Capital (ROIC) | 10.73% | 15.10% | 36.43% | 59.76% | 59.24% | 61.13% |
Return on Capital Employed (ROCE) | 11.30% | 14.20% | 22.60% | 22.80% | 23.60% | 26.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.57% | 2.12% | 2.30% | 1.92% | 1.42% | 0.92% |
FCF Yield | 1.08% | -0.26% | 0.19% | 1.41% | 3.85% | 0.14% |
Dividend Yield | 2.42% | 1.78% | 1.42% | 1.00% | 0.45% | 0.29% |
Payout Ratio | 108.58% | 91.16% | 71.46% | 28.05% | 30.77% | 23.41% |
Buyback Yield / Dilution | 0.07% | 0.15% | -0.16% | 0.02% | 0.07% | -0.00% |
Total Shareholder Return | 2.49% | 1.93% | 1.26% | 1.02% | 0.53% | 0.29% |